Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$46,939,497
+$1,092,576 QoQ
Shares Held
184,823
-1.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#459
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $157,042,184 across 12 Drug Manufacturers - General names. JNJ ranks #2 (29.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,791 | $60,920,254 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
184,823 | $46,939,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,634 | $18,025,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,736 | $12,173,576 | |
| 5 | NVS |
Novartis AG
|
29,237 | $4,582,022 | |
| 6 | AMGN |
Amgen Inc
|
12,190 | $4,414,242 | |
| 7 | PFE |
Pfizer Inc
|
142,810 | $3,438,864 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
42,788 | $2,465,444 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,939,497 | 184,823 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $45,846,921 | 187,559 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $40,378,635 | 195,113 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $35,252,977 | 190,125 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $29,782,736 | 194,977 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,467,974 | 189,749 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,113,549 | 194,396 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $31,753,874 | 195,939 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $29,120,918 | 199,240 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $29,520,310 | 186,613 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $29,330,599 | 187,129 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,074,504 | 90,366 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $13,166,122 | 79,544 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $10,573,170 | 68,214 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,188,850 | 69,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,272,003 | 69,001 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,187,841 | 79,927 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,013,998 | 73,430 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $13,056,062 | 76,320 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $12,571,967 | 77,845 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $13,036,699 | 79,135 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $13,146,685 | 79,992 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $12,368,808 | 78,592 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $11,849,061 | 79,588 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $11,288,791 | 80,273 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $10,608,548 | 80,901 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||